BASi 1Q Revenues: $10.9 million (+11%) 1Q Earnings: $556,000 (loss of $716,000 1Q2006) Comments: Bioanalytical and toxicology operations revenues increased in the quarter, revenues from product sales were flat, and revenues from clinical operations declined as a result of the loss of a significant client FY2006. The company had reduced selling, R&D, and general and administrative expenses to $2.7 million, compared to $4.1 million in 1Q2006. These expenses were favorably impacted ...